secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001640334-26-000162
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience shareholders elect all director nominees, ratify auditors at annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected: highest vote % John Docherty (96.4%), lowest Albert Reese Jr. (73.6%).
- Malone Bailey LLP ratified as auditors with 97.0% approval.
- Ratification of directors' past actions passed with 90.0% approval.
- 8,380,389 shares (37.71% of issued capital) represented at the meeting.
- Broker non-votes totaled 3,963,206 on director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033426000162/0001640334-26-000162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033426000162/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-000162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer